Anna Vilarrodona
Overview
Explore the profile of Anna Vilarrodona including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez Martinez J, Castells-Sala C, Baptista Piteira A, Montagner G, Trojan D, Martinez-Legazpi P, et al.
Ther Clin Risk Manag
. 2025 Mar;
21:209-228.
PMID: 40035073
Purpose: Cryopreserved homografts for valve replacement surgeries face a major problem regarding their durability after implantation and decellularized pulmonary heart valves have raised as potential new generation substitute for these...
2.
Navarro A, Len O, Muniz-Diaz E, Vives Corrons J, Dominguez-Gil B, Vilarrodona A, et al.
Front Transplant
. 2024 Jul;
3:1307946.
PMID: 38993767
Introduction: Biovigilance (BV) systems aim to improve the quality and safety of tissues and organs for transplantation. This study describes the Catalan BV system and analyzes its utility. Methods: It...
3.
Vila M, Xiberta P, Ruiz M, Bermudo R, Leivas D, Farinas O, et al.
Comput Biol Med
. 2024 May;
176:108553.
PMID: 38723397
Introduction: Tissue establishments are responsible for processing, testing, preserving, storing, and distributing allografts from donors to be transplanted into recipients. In some situations, a matching process is required to determine...
4.
Bayes-Genis A, Gastelurrutia P, Monguio-Tortajada M, Camara M, Prat-Vidal C, Cediel G, et al.
EBioMedicine
. 2024 Mar;
102:105060.
PMID: 38490102
Background: In preclinical studies, the use of double allogeneic grafts has shown promising results in promoting tissue revascularization, reducing infarct size, preventing adverse remodelling and fibrosis, and ultimately enhancing cardiac...
5.
Lopez-Chicon P, Perez M, Castells-Sala C, Piteira A, Farinas O, Tabera J, et al.
Ther Clin Risk Manag
. 2023 Jul;
19:567-578.
PMID: 37425344
Background: The activities of tissue establishments are constantly and rapidly evolving. The development of a new type of allograft, full-thickness acellular dermal matrix, with high mechanical properties to be used...
6.
Contreras E, Traserra S, Bolivar S, Nieto-Nicolau N, Jaramillo J, Fores J, et al.
Neurosurgery
. 2023 Jun;
93(6):1296-1304.
PMID: 37319401
Background And Objectives: Peripheral nerve injuries resulting in a nerve defect require surgical repair. The gold standard of autograft (AG) has several limitations, and therefore, new alternatives must be developed....
7.
Martinez-Conesa E, Otero N, Lopez P, Perez M, Savio A, Agusti E, et al.
BMJ Open Ophthalmol
. 2023 Jun;
7(Suppl 2):A2.
PMID: 37282690
Since the start of the pandemic, the tissue donation in Catalonia (Spain) has decreased drastically. At the beginning of the lockdown (from March to May 2020) there was a drop...
8.
Martinez-Conesa E, Sabater-Cruz N, Otero N, Agusti E, Casaroli-Marano R, Vilarrodona A
BMJ Open Ophthalmol
. 2023 Jun;
7(Suppl 2):A16.
PMID: 37282688
Purpose: To investigate the tolerability, security and long-term efficacy of lyophilized amniotic membrane (LAM) as an alternative to cryopreserved amniotic membrane in pterygium surgery. Material And Methods: Prospective case series...
9.
Agusti E, Martinez-Conesa E, Perez M, Sabater-Cruz N, Casaroli-Marano R, Vilarrodona A
BMJ Open Ophthalmol
. 2023 Jun;
7(Suppl 2):A13.
PMID: 37282681
Introduction: Our tissue establishment developed a protocol for processing amniotic membranes as extracts to be re-hydrated and administered topically as eye drops, becoming a new approach to treat severe ocular...
10.
Cuende N, Vilarrodona A, Vuelta E, Marazuela R, Herrera C, Querol S, et al.
Transplantation
. 2023 Feb;
107(4):867-877.
PMID: 36721301
In view of the public consultation recently launched by the World Health Organization on Regulatory Convergence of Cell and Gene Therapy Products and the Proposal for a Regulation on substances...